Microsurgery of a rare case of abducens schwannoma: surgical techniques.

IF 2.7 4区 医学 Q3 ONCOLOGY
Jingqi Hu, Hailiang Tang, Ming Xu, Jian Xu, Ping Zhong
{"title":"Microsurgery of a rare case of abducens schwannoma: surgical techniques.","authors":"Jingqi Hu, Hailiang Tang, Ming Xu, Jian Xu, Ping Zhong","doi":"10.21037/cco-2025-aw-126","DOIUrl":null,"url":null,"abstract":"<p><p>Abducens schwannoma is relatively very rare, and accounts for only about 1% of all intracranial schwannomas. Here, we report microsurgical resection of a rare case of cisternal-segment abducens schwannoma in a female patient. Upon physical examination, the patient showed no eye movement symptoms, and facial & auditory nerves function were normal, but showed slight unsteady walking and positive Romberg sign. Magnetic resonance imaging (MRI) scan of the brain revealed a mass located at the right cerebellopontine angle (CPA), and the tumor was partially enhanced after contrast MRI scan. Thus, schwannoma is suspected before surgery, but it's difficult to identify its origin by MRI images. Considering tumor compression to brain stem and available microsurgical techniques nowadays, we selected craniotomy surgery for the patient, and classic retro-sigmoid approach was recommended, which is a safe and commonly used surgical approach. During the surgery, the tumor was found to arise from the abducens nerve, and a total resection of the schwannoma was finally achieved under intra-operative neuro-monitoring. The patient tolerated the surgery very well, but had transient abducens paralysis and ataxia after surgery, and gradually improved in 3 months. The follow-up brain MRI images 3 months after surgery indicated no residual or relapse of the tumor.</p>","PeriodicalId":9945,"journal":{"name":"Chinese clinical oncology","volume":"15 1","pages":"5"},"PeriodicalIF":2.7000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cco-2025-aw-126","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abducens schwannoma is relatively very rare, and accounts for only about 1% of all intracranial schwannomas. Here, we report microsurgical resection of a rare case of cisternal-segment abducens schwannoma in a female patient. Upon physical examination, the patient showed no eye movement symptoms, and facial & auditory nerves function were normal, but showed slight unsteady walking and positive Romberg sign. Magnetic resonance imaging (MRI) scan of the brain revealed a mass located at the right cerebellopontine angle (CPA), and the tumor was partially enhanced after contrast MRI scan. Thus, schwannoma is suspected before surgery, but it's difficult to identify its origin by MRI images. Considering tumor compression to brain stem and available microsurgical techniques nowadays, we selected craniotomy surgery for the patient, and classic retro-sigmoid approach was recommended, which is a safe and commonly used surgical approach. During the surgery, the tumor was found to arise from the abducens nerve, and a total resection of the schwannoma was finally achieved under intra-operative neuro-monitoring. The patient tolerated the surgery very well, but had transient abducens paralysis and ataxia after surgery, and gradually improved in 3 months. The follow-up brain MRI images 3 months after surgery indicated no residual or relapse of the tumor.

罕见外展神经鞘瘤的显微外科治疗:手术技术。
外展神经鞘瘤相对罕见,仅占颅内神经鞘瘤的1%左右。在这里,我们报告显微手术切除一个罕见的病例池段外展神经鞘瘤的女性患者。经查体,患者无眼动症状,面部和听觉神经功能正常,但行走轻微不稳,Romberg征阳性。MRI扫描示右脑桥小脑角(CPA)肿块,MRI造影后肿瘤部分增强。因此,在手术前就怀疑神经鞘瘤,但很难通过MRI图像确定其起源。考虑到肿瘤对脑干的压迫及现有的显微外科技术,我们选择了开颅手术,并推荐经典的乙状窦后入路,这是一种安全且常用的手术入路。术中发现肿瘤起源于外展神经,术中神经监测下完成神经鞘瘤全切除。患者对手术耐受良好,但术后出现一过性外展肌麻痹和共济失调,3个月后逐渐好转。术后3个月随访的脑MRI图像显示肿瘤未残留或复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
期刊介绍: The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书